Join to View Full Profile
915 Olentangy River RdSte 4000Columbus, OH 43212
Phone+1 614-366-3687
Dr. Ren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Otolaryngology - Head and Neck Surgery, 2015 - 2019
Harvard Medical SchoolClass of 2014
Certifications & Licensure
OH State Medical License 2021 - 2027
CA State Medical License 2019 - 2023
MA State Medical License 2014 - 2019
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology- American Board of Otolaryngology - Head and Neck Surgery Neurotology
Publications & Presentations
PubMed
- Plasma Matrix Metalloproteinase-9 Predicts Intraoperative Experience and Extent of Resection in Vestibular Schwannoma Surgery.Han T N Nguyen, Robert J Macielak, Lisa Zhang, Oliver F Adunka, Kyle C Wu
Otolaryngology--Head and Neck Surgery. 2025-04-01 - Clinical Outcomes of Salvage Microsurgical Resection after Radiation Therapy for Sporadic Vestibular Schwannomas.Omid Moshtaghi, Patrick Barba, Peter Dixon, Yin Ren, Marc Schwartz
Journal of Neurological Surgery. Part B, Skull Base. 2025-04-01 - Quantitative Assessment of Collagen Architecture to Determine Role of Tumor Stroma During Vestibular Schwannoma Progression.Melanie Fisher, Bailey H Duhon, Han T N Nguyen, Jeffrey R Tonniges, Kyle C Wu
Otolaryngology--Head and Neck Surgery. 2025-02-01
Press Mentions
Four Physician Scientists Awarded Doris Duke Charitable Foundation Grants to Further Research Impacted by COVID-19April 6th, 2022- The 2 Best Ways to Remove Ear Wax, and 3 Methods to AvoidAugust 24th, 2021
2016 CORE Grant RecipientsMarch 5th, 2019
Grant Support
- Engineering protease biomarkers to guide surgical therapy for vestibular schwannoma and Neurofibromatosis Type 2OHIO STATE UNIVERSITY2023–2027
- Engineering protease biomarkers to guide surgical therapy for vestibular schwannoma and Neurofibromatosis Type 2OHIO STATE UNIVERSITY2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
